Evofem Biosciences Inc (OTCPK:EVFM)
$ 0.01 0.00004 (0.4%) Market Cap: 1.00 Mil Enterprise Value: 50.34 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q4 2018 Evofem Biosciences Inc Earnings Call Transcript

Mar 01, 2019 / 04:00PM GMT
Release Date Price: $6843.72 (-12.05%)
Operator

Good day, ladies and gentlemen, and welcome to Evofem Biosciences Conference Call. (Operator Instructions)

I would now like to introduce your host for today's conference, Amy Raskopf. Please begin.

Amy Raskopf
Evofem Biosciences, Inc. - Head of IR

Thank you, Norma. Good morning, everyone. And thanks for joining the Evofem Biosciences Fourth Quarter and Year-End 2018 Financial Results. This is Amy Raskopf, Investor Relations for Evofem.

If you have not already received it, please access the financial results press release issued earlier this morning on our website, evofem.com under Investors. A webcast of today's call is available there as well.

Various statements we make during this call about Evofem's business, strategy and plans are considered forward-looking statements for the purposes of the Safe Harbor provision under the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to numerous assumptions, risks and uncertainties which change overtime. Further information on the factors and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot